Related Experiment Video
Updated: Jun 19, 2026
07:06
Particle Agglutination Method for Poliovirus Identification
Published on: April 20, 2011
STUDIES IN AGGLUTINATION : IV. THE AGGLUTINATION INHIBITION ZONE
1Department of Medicine of the College of Physicians and Surgeons of Columbia University, and the Presbyterian Hospital, New York.
The Journal of Experimental Medicine
|October 30, 2009
Summary
Heating artificially creates an agglutination inhibition zone. This specific phenomenon depends on altered agglutinin, also known as agglutinoid, present in the serum.
Area of Science:
- Immunology
- Serology
Background:
- The study investigates the agglutination inhibition zone.
- This zone can be artificially produced through heating.
Purpose of the Study:
- To analyze the characteristics of the artificially produced agglutination inhibition zone.
- To determine the underlying mechanism of this phenomenon.
Main Methods:
- Heating serum to induce an inhibition zone.
- Observing and analyzing the properties of the induced zone.
Main Results:
- The agglutination inhibition zone produced by heating is a specific phenomenon.
- The presence of altered agglutinin (agglutinoid) in the serum is essential for its formation.
Conclusions:
- The study confirms the specificity of heat-induced agglutination inhibition.
- Altered agglutinin (agglutinoid) is identified as the key component responsible for this serological effect.
Related Concept Videos
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.